Valuation of the EORTC Quality of Life Utility Core 10 Dimensions (QLU-C10D) in a Multi-ethnic Asian Setting: How Does Having Cancer Matter?

被引:1
|
作者
Gandhi, Mihir [1 ,2 ,3 ,4 ]
Kanesvaran, Ravindran [5 ]
Rashid, Mohamad Farid Bin Harunal [5 ]
Chong, Dawn Qingqing [5 ]
Chay, Wen-Yee [5 ]
Tan, Rachel Lee-Yin [6 ]
Norman, Richard [7 ]
King, Madeleine T. [8 ]
Luo, Nan [6 ]
机构
[1] Consortium Clin Res & Innovat Singapore, Singapore Clin Res Inst, Biostat, Singapore, Singapore
[2] Duke NUS, Ctr Quantitat Med, Med Sch, Singapore, Singapore
[3] Duke NUS, Lien Ctr Palliat Care, Med Sch, Singapore, Singapore
[4] Tampere Univ, Tampere Ctr Child Adolescent & Maternal Hlth Res, Global Hlth Grp, Tampere, Finland
[5] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
[6] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[7] Curtin Univ, Sch Populat Hlth, Perth, Australia
[8] Univ Sydney, Sch Psychol, Sydney, Australia
基金
英国医学研究理事会;
关键词
GENERAL-POPULATION; EUROPEAN-ORGANIZATION; STATED PREFERENCES; COST-EFFECTIVENESS; CLINICAL-TRIALS; PATIENT; QUESTIONNAIRE; INSTRUMENT; OUTCOMES; ENGLISH;
D O I
10.1007/s40273-024-01432-5
中图分类号
F [经济];
学科分类号
02 ;
摘要
ObjectivesThe aim of the study was to develop and compare utility value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30, using the preferences of the general public and cancer patients in Singapore, and to assess their measurement properties.MethodsA total of 600 individuals from the general public were recruited using a multi-stage random sampling, along with 626 cancer patients with clinically confirmed diagnoses from outpatient clinics of the largest tertiary cancer hospital. Each participant valued 16 pairs of EORTC QLU-C10D health states using a discrete choice experiment (DCE). Conditional logit models were used to analyze the DCE responses of the general public and cancer patients separately. Utility values were assessed for known-group validity and responsiveness in the cancer patients by comparing mean values across subgroups of patients and calculating standardized response means using longitudinal EORTC QLQ-C30 data, respectively.ResultsPhysical functioning and pain had the most impact on utility for both cancer patients and general public groups. Worst health state utility values were -0.821 and -0.463 for the general public and cancer patients, respectively. Cancer patients' values were lower for mild-to-moderate health states but higher for moderately-to-highly impaired states compared with the general public's values. Both value sets discriminated between patients with differing characteristics and responded equally well to improved health status, but the cancer patients' value set was slightly more responsive to deteriorated health.ConclusionsEORTC QLU-C10D value sets based on the preferences of the Singaporean general public and cancer patients exhibited differences in values but similar psychometric properties.
引用
收藏
页码:1413 / 1425
页数:13
相关论文
共 11 条
  • [1] Chinese utility weights for the EORTC cancer-specific utility instrument QLU-C10D
    Cao, Yiyin
    Xu, Juan
    Norman, Richard
    King, Madeleine T.
    Kemmler, Georg
    Huang, Weidong
    Luo, Nan
    QUALITY OF LIFE RESEARCH, 2024, 33 (12) : 3335 - 3349
  • [2] Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma
    Seyringer, Simone
    Pilz, Micha J.
    Bottomley, Andrew
    King, Madeleine T.
    Norman, Richard
    Gamper, Eva M.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024,
  • [3] Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire
    Shiroiwa, T.
    King, M. T.
    Norman, R.
    Mueller, F.
    Campbell, R.
    Kemmler, G.
    Murata, T.
    Shimozuma, K.
    Fukuda, T.
    QUALITY OF LIFE RESEARCH, 2024, 33 (07) : 1865 - 1879
  • [4] QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
    King, M. T.
    Costa, D. S. J.
    Aaronson, N. K.
    Brazier, J. E.
    Cella, D. F.
    Fayers, P. M.
    Grimison, P.
    Janda, M.
    Kemmler, G.
    Norman, R.
    Pickard, A. S.
    Rowen, D.
    Velikova, G.
    Young, T. A.
    Viney, R.
    QUALITY OF LIFE RESEARCH, 2016, 25 (03) : 625 - 636
  • [5] German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30
    Kemmler, Georg
    Gamper, Eva
    Nerich, Virginie
    Norman, Richard
    Viney, Rosalie
    Holzner, Bernhard
    King, Madeleine
    QUALITY OF LIFE RESEARCH, 2019, 28 (12) : 3197 - 3211
  • [6] Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score
    Klapproth, Christoph Paul
    Fischer, Felix
    Rose, Matthias
    Karsten, Maria Margarete
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 152 : 101 - 109
  • [7] Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence
    Seyringer, Simone
    Pilz, Micha Johannes
    Jansen, Femke
    Buettner, Matthias
    King, Madeleine T.
    Norman, Richard
    Kemmler, Georg
    Nerich, Virginie
    Holzner, Bernhard
    Bottomley, Andrew
    Gamper, Eva M.
    EUROPEAN JOURNAL OF CANCER, 2025, 217
  • [8] Assessing health-related quality of life in cancer survivors: factors impacting on EORTC QLU-C10D-derived utility values
    van Gelder, Thomas
    Mulhern, Brendan
    Schoormans, Dounya
    Husson, Olga
    Lourenco, Richard de Abreu
    QUALITY OF LIFE RESEARCH, 2020, 29 (06) : 1483 - 1494
  • [9] The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands
    Pilz, Micha J.
    Seyringer, Simon
    Hallsson, Lara R.
    Bottomley, Andrew
    Jansen, Femke
    King, Madeleine T.
    Norman, Richard
    Rutten, Marianne J.
    Verdonck-de Leeuw, Irma M.
    Siersema, Peter D.
    Gamper, Eva Maria
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024, 25 (09) : 1539 - 1555
  • [10] Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs
    Pilz, Micha J.
    Seyringer, Simone
    Al-Naesan, Imad
    King, Madeleine T.
    Bottomley, Andrew
    Norman, Richard
    Schlosser, Lisa
    Hell, Tobias
    Gamper, Eva Maria
    PHARMACOECONOMICS-OPEN, 2024, 8 (04) : 627 - 640